# The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD)

> **NCT01032304** · PHASE3 · UNKNOWN · sponsor: **Edmond Pharma** · enrollment: 492 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** Erdosteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01032304
- **Lead sponsor:** Edmond Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2014-03
- **Final completion:** 2015-09
- **Target enrollment:** 492 (ESTIMATED)
- **Last updated:** 2014-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01032304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01032304, "The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01032304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*